Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Chronic Obstructive Pulmory Disease (COPD) - Overview
Chronic Obstructive Pulmory Disease (COPD) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Chronic Obstructive Pulmory Disease (COPD) - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Chronic Obstructive Pulmory Disease (COPD) - Companies Involved in Therapeutics Development
Chronic Obstructive Pulmory Disease (COPD) - Drug Profiles
Chronic Obstructive Pulmory Disease (COPD) - Dormant Projects
Chronic Obstructive Pulmory Disease (COPD) - Discontinued Products
Chronic Obstructive Pulmory Disease (COPD) - Product Development Milestones
Featured News & Press Releases
Aug 09, 2022: Dimerix announces new patent family application for DMX-700
Aug 09, 2022: Vero Pharma to announce top-line data from Phase 3 ENHANCE-2 Trial of nebulized ensifentrine for COPD
Aug 09, 2022: Vero Pharma announces ensifentrine meets primary endpoint in phase 3 ENHANCE-2 trial for COPD
Jul 11, 2022: RS Biotherapeutics reports positive results from proof-of-concept trial for first investigatiol compound
Jul 04, 2022: DMX-700 shows significant efficacy with 80% reduction in lung injury of COPD
Jun 09, 2022: Vero Pharma completes enrollment in phase 3 ENHANCE-1 trial evaluating ensifentrine for maintence treatment of COPD
Jun 06, 2022: Vero Pharma to host KOL event on June 16, 2022
May 23, 2022: Therapeutic Solutions Intertiol receives IND number 28508 for Chronic Obstructive Pulmory Disease clinical trial and enters binding discussions with FDA for initiation of phase I/II Clinical Trial
May 18, 2022: Successful completion of phase I study for lead asset EP395
May 18, 2022: Vero Pharma to present successful TQT alysis demonstrating no clinically relevant effect on cardiac conduction at the American Thoracic Society 2022
May 12, 2022: Phase III lung Adult Stem Cell company announces and files patent on leukine-induced myeloid derived suppressor cells and JadiCell for treatment of COPD
May 09, 2022: Therapeutic Solutions Intertiol files Investigatiol New Drug application for treatment of Chronic Obstructive Pulmory Disease (COPD) using JadiCell universal donor adult stem cells
Mar 31, 2022: Kither Biotech announces publication of new data in Science Translatiol Medicine
Mar 28, 2022: Sanofi continues on path to industry leadership in Immunology with Dupixent (dupilumab) as key driver
Mar 21, 2022: Pulmatrix announces positive top-line data evaluating PUR1800 in Patients with Stable COPD
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Chronic Obstructive Pulmonary Disease (COPD), 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Number of Products by Top 10 Targets, 2022
Number of Products by Stage and Top 10 Targets, 2022
Number of Products by Top 10 Mechanism of Actions, 2022
Number of Products by Stage and Top 10 Mechanism of Actions, 2022
Number of Products by Top 10 Routes of Administration, 2022
Number of Products by Stage and Top 10 Routes of Administration, 2022
Number of Products by Top 10 Molecule Types, 2022
Number of Products by Stage and Top 10 Molecule Types, 2022

List of Tables

List of Tables
Number of Products under Development for Chronic Obstructive Pulmonary Disease (COPD), 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects, 2022
Chronic Obstructive Pulmonary Disease (COPD) - Discontinued Products, 2022